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PITUITARY-ADRENICORTICAL FUNCTIONING IN PATIENTS
WITH ATOPIC DERMATITIS*
THOMAS H. STERNBERG, M. D., PATRICK BUTLER, M. D. AND
MURRAY C. ZIMMERMAN, M. D.
The physiological effects of emotional and physical stress on the human
organism have received considerable attention during recent years. Selye (1)
has shown that certain diseases and conditions may largely depend on a de-
rangement of the pituitary-adrenocortical response to stress. He has referred to
these diseases, which include rheumatic and rheumatoid conditions, allergic and
anaphylactic phenomena, certain hypertensive diseases, nephrosclerosis and
certain of the collagen diseases as "Diseases of Adaptation". Pincus and co-
workers (2, 3), Michael (4), Thorn (5) and others have shown that in normal
individuals a stress situation sets off an "alarm reaction" which produces changes
demonstrable within four hours. The more important of these are:
(1) A drop in the total eosinophil count.
(2) A decrease in the lymphocytes and an increase in total leukocytes.
(3) An increase in urinary uric acid excretion.
(4) An increase in urinary steroid output.
(5) Changes in the electrolyte composition of thermal sweat with a lowered
concentration of sodium and chloride.
The injection of epinephrine has also been shown to produce the "alarm
reaction" and it has been theorized by Long (6) that all stresses, whether mental
or physical, act through the release of epinephrine. This drug then stimulates
the anterior pituitary gland with release of ACTH which in turn produces an
outpouring of adrenocortical secretions.
The present paper is the preliminary report of a long range study of the
pituitary-adrenocortical functioning of individuals with atopic dermatitis and
lupus erythematosus. The study was suggested by a number of points of evidence
which seemed to indicate that abnormalities of the pituitary-adrenal cortical
response might be present in both of these diseases. As mentioned above, Selye
(1) and others have presented evidence suggesting that lupus erythematosus and
allergic and anaphylactic phenomena are "Diseases of Adaptation". Stokes (7)
particularly has emphasized for many years the abnormal response to physical
and mental stress of atopic individuals. The recently demonstrated response
of both lupus erythematosus and atopic dermatitis, sometimes in a most dramatic
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manner, to ACTH and Cortisone therapy has added more evidence of a vital
link between the pituitary and adrenal cortex and the etiologic mechanism of
these diseases. For these reasons, an investigation of the endocrine factors in
atopic dermatitis and in lupus erythematosus has been undertaken.
This paper deals with the pituitary-adrenocortical response of atopic individu-
als to adrenalin and to a deliberately applied stress situation. Subsequent papers
will expand the data in atopics and also consider lupus erythematosus.
MATERIALS AND METHODS
The subjects in this experiment consist of 7 normal controls, and 8 patients
with severe chronic atopic dermatitis. The controls were all in excellent physical
condition at the time they were studied, and had no history of recent illness or
of past episodes of eczema, asthma, hayfever or collagen diseases. They were
included as controls on technic, since by the experimental design, the abnormal
patients were controls on themselves. The eight subjects with atopic dermatitis
are shown in Table I. Their average age is 30 years; 6 were males and 2 were
females. They were arbitrarily selected for this study because the history and
clinical picture were typical of the disease.
Methods: In order to minimize the influence of variables such as differences
in diet, exercise and mental stress situations prior to testing, the following
technic was used for both controls and atopics.
The subjects were instructed to go to bed early the night before each test day,
indulging in no avoidable physical or mental stress situations. They were not
allowed food from midnight the night before, and they had no food until 2 P. M.
on the test day. The initial battery of tests was done at 8 A. M. following which
the patient was given either "no stress" (control), epinephrine (0.01 mg./kg.
body weight) or the stress situation.
The stress situation used in these experiments followed that of Pincus (2) and
consisted of one hour in a hot room in which the temperature was kept between
100110°, and the humidity at 90—95%. Each subject, control or tesib, was
studied on three different days, at least 3 days being allowed between each of
the 2 stress tests. The first test day was "no stress" control day, in which the
various laboratory procedures were done whiJe the subject was kept inactive.
The second test day consisted of measuring the response to epinephrine, and the
third test day of measuring the response to the stress situation. The "no stress"
or control day was done first in order to condition the patient to the experiment
and to minimize psychological stress from the experiment itself on subsequent
days.
All subjects were studied identically on each test day, at 8 A. M., 10 A. M.,
12 noon and 2 P. M. as follows:
(a) Total eosinophil count by the Thorn (5) modification of the Dunger technic.
(b) Total white count.
On each of these counts two pipettes were used, and two chambers were
counted from the contents of each pipette to minimize laboratory error. All
counts were averaged.
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(c) Differential count from slide smear, 200 cells being counted. All differen-
tial counts were done by the same individual.
(d) Uric acid and creatinine levels (urinary) were determined, urine specimens
being taken at 8 A. M. and 12:30 P. M., with at least one voiding between these
times.
TABLE I
A topic Dermatitis Patients
TIALS AGE SEX
SEVERITY
AT TIME
OP TEST
DURATION
OF THIS
ATTACK
PRESENCE
OF OTHER
COMPONENTS
OF EAHF
SEVERITY OF
OTHER COM
PONENTS AT
TIME OP TEST
COMMENT ON PATIENTS
WW 29 d' ++++ 13 yrs. History 0 Severe, generalized atopic der-
of hives matitis, keeping pt. hospi-
talized six months at a time,
refractory to all I.
JM 28 " +++ 4 yrs. Occas. 0 Infantile eczema, one child-
asthma hood flare-up. Clear while
bomber pilot in combat,
flaring continuously during 4
yrs. after. Clears in hospital,
flares on discharge.
NG 28 " + 3 yrs. Occas. 0 Mild lichenification, anticubital
asthma spaces and sides of neck.
SG 44 " ++++ life Constant Severe Severe,weepinggeneralizedder-
asthma asthma matitis. Never asymptomatic,
worse when tested. Four days
of ACTH completely cleared
dermatitis + asthma. Asymp-
tomatic on maintenance dose.
ER 31 " ++ 3 yrs. Occas. 0 Intermittent, mild atopic der-
hives matitis since childhood.
ME 34 ++ yrs. none 0 Moderately severe atopic der-
matitis in partial remission at
time of testing.
MP 26 + 2 yrs. none 0 No previous EAHF history or
symptoms. Following first
stress situation—realization
of daughter's prognosis after
excision of Wilms' tumor—pt.
developed classical atopic der-
matitis of anticubital
flexors + sides of neck.
FM 24 " ++++ life Severe Severe Severe atopic dermatitis, con-
asthma asthma stant, with occasional flares
of asthma.
PRESENTATION OF DATA
The raw data for the controls and the test subjects are shown in Tables II
and III respectively. These data represent the actual counts or laboratory de-
terminations. However, in order to interpret the data more clearly, certain
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arbitrary methods of presentation have been adopted. Since the initial 8 A. M.
eosinophil counts normally vary from individual to individual, this initial count
has been considered as "zero" for the subject being tested. Plus or minus changes
at subsequent times are then recorded as percentages of the original 8 A. M.
reading. Thus, if the initial eosinophil count is 40 and the 10 A. M. reading is
80, it is recorded as pius 100%.
Analysis of Changes in Eosinophils: Chart I shows changes in eosinophil
counts in the seven control subjects. The response curves represent the averages
(mean) for all seven of the subjects. With "no stress", the total eosinophils in-
creased at 10 A. M. to +37% and remained at about that level until 2 P. M.
coNrRoLs EOSINOPHIL COUNTS
EXPRESSED AS PERCENT OF BASAL LEVEL
C
a,0
a.
Following epinephrine, the mean eosinophil count was depressed 51% at 10
A. M., 74% at 12 noon and 71% at 2 P. M. Following the hot room stress, the
eosinophil count was decreased 55% at 10 A. M., 45% at 12 noon and 17% at
2 P. M. Thus, in the controls the eosinophil counts were lowered about the same
degree following epinephrine as following "hot room" stress. As shown in Table
II, there is considerable variation in the response of individual subjects. How-
ever, the average changes for our group of controls are consistent with that ob-
tained by other investigators in "normal" individuals.
In Chart II are shown the changes in the eosinophils in eight subjects with
atopic dermatitis. As with the controls, the chart represents averages (mean)
for the eight subjects, the individual variations being shown in Table II. With
"no stress", there was little change in the total eosinophil count between 8
A. M. and 2 P. M. Following epinephrine, the eosinophil count was depressed
43% at 10 A. M., 62% at 12 noon, 47% at 2 P. M. These changes following
/
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epinephrine in the atopic individuals are nearly identical with the epinephrine
response in the control subjects. However, following the hot room stress, there
was an increase in the total eosinophil count of 47% at 10 A. M., 31% at noon
and 27% at 2 P. M. This is a marked deviation from the controls as shown in
Chart I and from previously reported investigations in normal subjects.
ATOP/C DERMAT/T/CS EOSINOPHIL COUNTS
EXPRESSED AS PERCENT OF BASAL LEVEL
COA'TflOLS LYMPHOCYTE - NEUTROPHIL RATIO
EXPRESSED AS PERCENT OF BASAL LEVEL
CHART III
Lymphocyte-Neutrophil Ratio (L/N): In Charts III and IV are shown changes
in the lymphocyte-neutrophil ratio in the control subjects and in the atopics
respectively. These changes in ratios were computed by converting all readings
to decimals. The 8 A. M. reading was considered "zero" and subsequent read-
ings calculated accordingly. In the control subjects (Chart III) the readings
following "no stress" were +11% at 10 A. M., +12% at 12 noon and —3%
at 2 P. M. Following epinephrine there was a depression of 19% at 10 A. M.,
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22% at 12 noon and 12% at 2 P. M. Following hot room stress there was an
increase of 21% at 10 A. M., 4% at 12 noon and 15% at 2 P. M. These latter
findings are inconsistent for a control group following this particular stress
situation and we are unable to offer an explanation.
The average response of the L/N ratio in the atopics is shown in Chart IV.
With no stress there was an increase of +35% at 10 A. M., a drop to —3% at
ATOP/CS' LYMPHOCYTE - NEUTROPHIL RATIO
EXPRESSED AS PERCENT OF BASAL LEVEL
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CHAiIT IV
CONTROLS URIC ACID-CREATININE RATIO
EXPRESSED AS PERCENT OF BASAL LEVEL
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—25
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CHAXtT V
12 noon and an increase to +40% at 2 P. M. Epinephrine produced a drop to
—20% at 10 A. M., —8% at 12 noon and —6% at 2 P. M. Following hot room
stress, there was an increase of +16% at 10 A. M., a drop to —30% at 12 noon
with a rise to +9% at 2 P. M.
These data show considerable variation and statistical analysis is not pos-
sible. Perhaps as the experiment is enlarged the apparently abnormal findings
may become significant.
Changes in Uric Acid-Creatinine Ratio: As shown in Tables II and III the
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uric acid and the creatinine are reported on the basis of milligrams per cent. In
Charts V and VI, changes have been converted to percentage increase and so
recorded. The controls (Chart V) showed a small increase of 5% following "no
stress" and of 8% following the hot room. Following epinephrine, however,
there was a marked increase of 43% in the ratio. In the atopics (Chart VI)
ATOP/CS URIC ACID —CREATININE RAllO
EXPRESSED AS PERCENT OF BASAL LEVEL
8am 1200
CIMET VI
ATOP/CS vs CONTROLS COMPARISON OF
EOSINOPHIL RESPONSE TO STRESSES
there was an increase of 1% following "no stress" of 3% following the hot room
and of 10% following epinephrine.
DISCUSSION
Chart VII was prepared to emphasize the divergence between controls and
atopies of the eosinophii response following the stress situation. It is seen that
after epinephrine both the atopics and the normal subjects showed a similar and
normal drop in the eosinophil count. In both groups the decrease was below the
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—50% level considered by Thorn et al. (5) as the normal "eosinopenic index"
of pituitary-adrenal function.
After one hour in the "hot room" the control group showed a similar drop.
The atopics, however, had a rising eosinophil count exactly opposite to the
expected response. While individual variations, as shown in Table III, were
fairly great, this difference in response when subjected to statistical analysis
was highly significant by both chi square and analysis of variance technic
(p = less than 0.1%). It is believed, however, that because of the small group
involved, final judgment of the significance of these changes should be reserved.
The findings relative to the L/N ratios and the U/C ratio suggest that here
too atopics do not follow the normal pattern of stress response. At the present
degrees of freedom, however, these abnormal trends do not have statistical
significance.
The eosinophil count is generally considered the most reliable and sensitive
index of pituitary-adrenocortical activity. We have demonstrated that individu-
als with atopic dermatitis, as measured by this index, do not respond normally
to an artificially produced stress situation. Theoretically, the fault should be
either in the anterior pituitary gland, the adrenal cortex, the adrenal medulla,
or the hypothalamus. The anterior pituitary gland and the adrenal cortex were
at least capable of a normal response in atopics, since the eosinopenic index was
normal following an injection of epinephrine. This fact would seem to localize
the fault either to the adrenal medulla or the hypothalamus, or both.
According to Carlson (8), the adrenal medulla is the only endocrine gland
under direct nervous control, and experimental stimulation of its cut efferent
nerves will result in an outpouring of epinephrine. There is reason to believe
that in atopics the adrenal medulla may become exhausted as the result of
repeated stresses, and thus incapable of initiating the "alarm reaction" through
secretion of epinephrine. It is also possible that as a result of repeated stresses
in the atopic, a relative epinephrine refractoriness develops. Supporting this
latter view, it is known that in normal individuals a relative refractory period
up to 4 days follows an injection of epinephrine. (4)
Failure of the pituitary-adrenal cortical mechanism may be due to abnormal
function of the hypothalamus. It has been demonstrated in dogs by Hume (9)
that an intact hypothalamus is essential for the initiation of the "alarm reac-
tion" response following stress or epinephrine. This response occurs even after
the pituitary stalk is completely separated from the hypothalamus by an im-
permeable plastic film. Hume suggests, as does Scharrer (10), that there are
secreting cells in the hypothalamus and that the hypothalamic control of the
pituitary gland is on a hormonal basis. Thus, a hypothalamic lesion could also
account for our results.
Other explanations for failure of the atopics to respond normally to stress can
be offered. It is possible that any chronic extensive dermatitis is capable of
altering pituitary-adrenocortical response to stress. It is also possible that the
abnormal eosinopenic index in atopics following "hot room" stress may be
temporary and disappear during remissions. This is being investigated.
Further evidence of the integral relationship of anterior pituitary-adreno-
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cortical functioning in atopic dermatitis is well illustrated by the following case
report.
The most severely affected patient in our series, S. G., who had exudative
atopic dermatitis of almost universal distribution, was hospitalized May 8,
1950, and after a 1 mg. test dose, given adrenocorticotropic hormone, 10 mg.
every 6 hours intramuscularly. His exudation and itching disappeared within
48 hours and after 4 days his skin was practically healed (with the exception of
residual lichenification) for the first time in many years. During this treatment
his initial eosinophil count of 3600 dropped to 88. After two weeks, the dosage
of ACTH was cut to 25 mg. once daily. The following day his eosinophil count
jumped to 800, and the second day itching, erythema, and exudation appeared
on his face and groin. The ACTH dosage was then increased to 60 mg. daily,
(15 mg. every six hours) with immediate healing of his skin. S. G. has now been
on ACTH for six weeks. Every attempt to reduce the dosage below 40 mg. daily
is followed by a relapse. However, he continues to respond to adequate daily
ACTH therapy. This suggests a minimal daily requirement similar to the insulin
needs of a diabetic.
The complexity of the problem of pituitary adrenocortical function is indi-
cated by the present state of flux in the literature, and the numerous contra-
dictory reports. Recent data suggest that there may be at least two separate
adrenocorticotrophins and about 31 adrenocortical steroids. The mode of action
and the physiologic and pathologic effects of these hormones remain largely
undetermined.
SUMMARY
1. A study of the pituitary-adrenocortical function in 7 normal persons and
8 atopics is reported, as measured by changes in the eosinophil counts, lympho-.
cyte-neutrophil ratio, and uric-acid-creatinine ratio.
2. The two groups show approximately the same reaction after stimulation
with epinephrine, but a marked and dramatic difference in eosinophil response
after a physiological stress situation (one hour in a "hot room"). While this
difference is significant on statistical analysis, it is believed that final evaluation
should be withheld pending confirmation in larger groups.
3. Differences in response as reflected by lymphocyte-neutrophil ratio and
uric acid creatinine ratios are present, but with the allowable degree of freedom,
these differences do not have statistical significance.
4. A discussion of possible causes of these abnormal responses in atopic in-
dividuals is presented. A derangement of the hypothalamus, or some abnormality
related to the adrenal medulla are suggested as possibilities.
5. The treatment of one of the atopic patients with ACTH is reported.
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